BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28624960)

  • 1. Drug-Induced Pyoderma Gangrenosum: A Review.
    Wang JY; French LE; Shear NH; Amiri A; Alavi A
    Am J Clin Dermatol; 2018 Feb; 19(1):67-77. PubMed ID: 28624960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced pyoderma gangrenosum: a model to understand the pathogenesis of pyoderma gangrenosum.
    Wu BC; Patel ED; Ortega-Loayza AG
    Br J Dermatol; 2017 Jul; 177(1):72-83. PubMed ID: 27864925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of pyoderma gangrenosum induced by insulin.
    Noronha M; Arora S; Pai K; Sathish Pai B; Jindal A
    Int Wound J; 2019 Oct; 16(5):1239-1242. PubMed ID: 31353778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of pyoderma gangrenosum possibly associated with sunitinib treatment.
    Ueharaguchi Y; Kabashima K; Sasahashi M; Matsuda A; Matubara K; Matsui M
    Int J Dermatol; 2013 May; 52(5):634-6. PubMed ID: 23590380
    [No Abstract]   [Full Text] [Related]  

  • 5. Tyrosine kinase inhibitors-associated pyoderma gangrenosum, a systematic review of published case reports.
    Khoshnam-Rad N; Gheymati A; Jahangard-Rafsanjani Z
    Anticancer Drugs; 2022 Jan; 33(1):e1-e8. PubMed ID: 34282745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyoderma Gangrenosum Associated with Sunitinib: A Case Report.
    Sevimli Dikicier B
    Adv Skin Wound Care; 2019 Sep; 32(9):427-429. PubMed ID: 31408027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyoderma gangrenosum following treatment with isotretinoin.
    Gangaram HB; Tan LP; Gan AT; Suraiya HH; Ganesapillai T
    Br J Dermatol; 1997 Apr; 136(4):636-7. PubMed ID: 9155981
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pyoderma gangrenosum associated with anti-proteinase 3 antineutrophil cytoplasmic antibodies (PR3-ANCA) induced by propylthiouracil].
    Coster A; Dargent JL; de Visscher N; Levecque P; Roquet-Gravy PP
    Ann Dermatol Venereol; 2017 May; 144(5):368-373. PubMed ID: 28291538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sunitinib induced pyoderma gangrenosum-like ulcerations.
    Akanay-Diesel S; Hoff NP; Kürle S; Haes J; Erhardt A; Häussinger D; Schulte KW; Bölke E; Matuschek C; Budach W; Gerber PA; Homey B
    Eur J Med Res; 2011 Nov; 16(11):491-4. PubMed ID: 22027642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imatinib induced pyoderma gangrenosum.
    Pinato DJ; Sharma R
    J Postgrad Med; 2013; 59(3):244-5. PubMed ID: 24029213
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of propylthiouracil-induced pyoderma gangrenosum associated with antineutrophil cytoplasmic antibody.
    Hong SB; Lee MH
    Dermatology; 2004; 208(4):339-41. PubMed ID: 15178918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyoderma gangrenosum: another cutaneous side-effect of sunitinib?
    ten Freyhaus K; Homey B; Bieber T; Wilsmann-Theis D
    Br J Dermatol; 2008 Jul; 159(1):242-3. PubMed ID: 18489600
    [No Abstract]   [Full Text] [Related]  

  • 14. Pyoderma gangrenosum--a review.
    Wollina U
    Orphanet J Rare Dis; 2007 Apr; 2():19. PubMed ID: 17433111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology and management of pyoderma gangrenosum: a comprehensive review.
    Ahronowitz I; Harp J; Shinkai K
    Am J Clin Dermatol; 2012 Jun; 13(3):191-211. PubMed ID: 22356259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pyoderma gangrenosum: case series].
    Richetta AG; Maiani E; Carboni V; Carlomagno V; Cimillo M; Mattozzi C; Calvieri S
    Clin Ter; 2007; 158(4):325-9. PubMed ID: 17953284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inpatient management of pyoderma gangrenosum: treatments, outcomes, and clinical implications.
    Cabalag MS; Wasiak J; Lim SW; Raiola FB
    Ann Plast Surg; 2015 Mar; 74(3):354-60. PubMed ID: 23903083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophilic dermatoses: a review of current treatment options.
    Cohen PR
    Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyoderma gangrenosum.
    Maverakis E; Marzano AV; Le ST; Callen JP; Brüggen MC; Guenova E; Dissemond J; Shinkai K; Langan SM
    Nat Rev Dis Primers; 2020 Oct; 6(1):81. PubMed ID: 33033263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suspected induction of a pyoderma gangrenosum-like eruption due to sulpiride treatment.
    Srebrnik A; Shachar E; Brenner S
    Cutis; 2001 Mar; 67(3):253-6. PubMed ID: 11270303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.